Hydrogen Therapy Delays ALS Progression in Mice

TL;DR

Treating mice with a form of ALS with hydrogen-rich saline improved their symptoms and extended their lives by reducing harmful oxidative stress and preserving nerve cell health.

Key Finding

Hydrogen-rich saline treatment significantly delayed disease onset and extended survival in mice with ALS while reducing nerve cell death and protecting mitochondrial function.

Summary

Researchers tested whether hydrogen-rich saline (a solution containing dissolved hydrogen gas) could help slow down ALS, a disease that damages nerve cells controlling muscles. In mice genetically engineered to develop ALS, the treatment delayed when symptoms started, extended survival time, and reduced nerve cell death. The hydrogen appeared to work by reducing harmful molecules called free radicals (unstable atoms that damage cells) and protecting the energy-producing structures inside cells called mitochondria.

Practical Takeaway

This is an early-stage animal study showing hydrogen may have protective effects against ALS-related nerve damage through antioxidant mechanisms. However, results in mice do not automatically translate to humans, and no human trials have been conducted. Much more research, including human clinical trials, would be needed before any conclusions could be drawn about hydrogen's usefulness for ALS patients.

Abstract (excerpt)

Amyotrophic lateral sclerosis (ALS) is the most frequent adult-onset motor neuron disease, and accumulating evidence indicates that oxidative mechanisms contribute to ALS pathology, but classical antioxidants have not performed well in clinical trials. The aim of this work was to investigate…

Read the full abstract via DOI